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Glucose is the preferred energy substrate for the adult brain.
The blood—brain barrier (BBB) restricts the uptake of other
plentiful potential substrates such as monocarboxylates
(reviewed by Cremer, 1982), although recent evidence
suggests that the permeability of the BBB to lactate is
higher than previously estimated (Hassel & Brathe, 2000).
In healthy individuals, plasma glucose is critically regulated
to ensure adequate supplies to the CNS and other tissues.
While the BBB restricts access to energy supplies other than
glucose, the concept has developed that astroglia and neurons
compose a functional energy supply unit, with most glucose
utilisation occurring in the astroglia. Glia then export lactate
as an energy source that can be utilised by neurons. Thus,
once within the compartment defined by the blood—brain
barrier the major energy currency for use by neurons is
postulated to be lactate. This process has been termed the
lactate shuttle and is particularly important during periods
of energy demand (Tsacoupolos & Magistretti, 1996).
When normal physiological maintenance of blood glucose
fails, as in patients with insulin-dependent diabetes mellitus
who suffer an insulin overdose, severe hypoglycaemia leads
to loss of conciousness and, rarely, coma and death. In
addition, there is now increasing evidence that, repeated
severe hypoglycaemic episodes, although apparently
resolving with full recovery, do correlate with long term
cognitive decline and loss of hippocampal volume as
determined by magnetic resonance imaging (Perros et al.
1997). In addition to acute interruptions in glucose supply
to the whole brain, at the cellular level impairment in
glucose transport with ageing may result in slow neuro-
degeneration (Mark et al. 1997). Thus there is considerable
interest in understanding the cellular mechanisms essential
for energy utilisation in the adult CNS.
A number of functional studies have been performed on
acute preparations of cortical and hippocampal slices to
substantiate the lactate shuttle hypothesis. Acute cortical
slice experiments have shown that lactate can replace glucose
to maintain synaptic activity (Schurr et al. 1988) and that
lactate supplies the increased energy demands that result
from activation of excitatory glutamatergic pathways (Schurr
et al. 1999). Further acute experiments have demonstrated a
role for lactate in pathophysiological protocols. Lactate,
rather than glucose, fuels the recovery of function from
hypoxia (Schurr et al. 1997a) and glia are the source of lactate
(Schurr et al. 1997b). Izumi et al. (1997) used metabolic
pathway inhibitors to provide further support for an
important role of lactate and other monocarboxylates in
supporting synaptic transmission in conditions of glucose
deprivation.
Substrate utilisation by the brain during development shows
important differences. Suckling neonates are more able to
utilise circulating monocarboxylates, such as lactate, in part
due to upregulation of expression of monocarboxylate
transporters in cerebrovascular endothelia immediately
postnatal (Pellerin et al. 1998). However, relatively little is
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1. The effects of energy substrate removal and metabolic pathway block have been examined on
neuronal and glial survival in organotypic slice cultures of rat hippocampus.
2. Slice cultures resisted 24 h of exogenous energy substrate deprivation. Application of 0·5 mÒ
á-cyano-4-hydroxycinnamate (4-CIN) for 24 h resulted in specific damage to neuronal cell
layers, which could be reversed by co-application of 5 mÒ lactate.
3. Addition of 10 mÒ 2-deoxyglucose in the absence of exogenous energy supply produced
widespread cell death throughout the slice. This was partly reversed by co-application of
5 mÒ lactate.
4. These effects of metabolic blockade on cell survival were qualitatively similar to the effects on
population spikes recorded in the CA1 cell layer following 60 min application of these agents.
5. The data suggest that monocarboxylate trafficking from glia to neurons is an essential route
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known of the functional expression of substrate utilisation
pathways in the brain parenchyma during development and
their physiological and pathophysiological importance. In
infants, hypoglycaemia occurs as a result of a number of
conditions of which the most common is persistent hyper-
insulinaemic hypoglycaemia of infancy (PHHI), with an
incidence of about 1:2500 newborns in Caucasian
populations (reviewed by Aynsley-Green et al. 1998). Post
mortem analysis of human infants and animal studies show
characteristic patterns of neuronal cell death that differ
from that resulting from hypoxia or ischaemia. For example,
in the hippocampus, the dentate gyrus is much more
sensitive than the CA1 and CA3 pyramidal cell layers to
hypoglycaemic insults (Auer & Siesjo, 1988).
We have used organotypic hippocampal slices to examine
the role of energy substrates on neuronal survival after 24 h
of hypoglycaemia. Our aim was to investigate the
contributions of the lactate shuttle to energy supply in the
various neuronal cell layers of the hippocampus that
differentially express monocarboxylate transporters (MCTs).
In addition, we wanted to examine the importance of the
lactate shuttle in a neonatal culture system, which might
differ from adult tissue. The slice cultures are resistant to
damage by short periods of glucose deprivation unless lactate
transport is pharmacologically blocked, when pyramidal
and granule cell death results. Our results suggest that the
provision of lactate by glia as a neuronal energy substrate is
an important facet of energy utilisation.
METHODS
Organotypic hippocampal slice cultures were prepared as described
by Stoppini et al. (1991). Neonatal Wistar rats (8—10 days old) were
killed by decapitation, the hippocampus was rapidly dissected, and
transverse sections (400 ìm) were cut on a McIlwain tissue chopper
and immediately placed into ice-cold Geys balanced salt solution
(GBSS; Gibco, UK) supplemented with 5 mg ml¢ glucose. Slices
were plated onto sterile, semiporous tissue culture inserts (Millicell-
CM, Millipore, UK, four slices per well) and maintained in culture
at 37°C in a 5% COµ atmosphere. The support medium consisted
of 50% minimum essential medium (MEM, Gibco, UK), 25%
Hanks’ balanced salt solution (HBSS; Gibco, UK) and 25% heat-
inactivated horse serum (ICN, UK) supplemented with 5 mg ml¢
glucose and 1 mÒ glutamine (Sigma). The medium was changed
every 3 days and cultures were used for experiments after 14 days
in vitro.
Slice cultures were then transferred into serum free medium (SF:
100% MEM, 1 mÒ glutamine, 5 mg ml¢ glucose) containing
5 ìg ml¢ propidium iodide (PI; Molecular Probes, USA) for 20 min
and then imaged under a fluoroescence microscope fitted with a
rhodamine filter. Any cultures exhibiting fluorescence at this stage
were discarded from further study. Following this, cultures were
placed into SF medium with 5 ìg ml¢ PI and containing either no
substrate (GFM: glucose-free medium); energy substrate (30 mÒ
glucose, 5 mÒ lactate); metabolic inhibitor (10 mÒ 2-deoxyglucose,
0·25—5 mÒ 4-CIN, 10—70 ìÒ quercetin); or a combination of
metabolic inhibitor and substrate. After 24 h incubation under
appropriate experimental conditions, cultures were imaged for PI
fluorescence and then fixed in 4% paraformaldehyde and stained
with thionine. PI fluorescence was excited between 515 and 560 nm
using a mercury vapour lamp and observed using a standard Leica
inverted microscope fitted with a rhodamine filter. Images were
captured using a monochrome CCD video camera and frame
grabber, stored on either magnetic optical discs or on compact disc,
and were later analysed using NIH Image 1.55 software.
Quantification of cell damage was determined as previously
described by Pringle et al. (1996) and results are expressed as the
percentage area of each hippocampal subfield in which fluorescence
was observed. Results are expressed as means ± s.e.m. Significance
was determined by one way ANOVA followed by Dunnett’s post-
test.
Stocks (100 mÒ) of lactate, glucose, pyruvate and 2-deoxyglucose
(Sigma) were all made up in GF medium to give either a 1 Ò or
100 mÒ stock so that the substrate was added to the medium to
give no more than 1:10 dilution. á_Cyano-4-hydroxycinnamate
(4-CIN) (Sigma, UK) was initially dissolved in heated methanol to
give a 100 mÒ stock solution. This was then further diluted to
either 1:5 or 1:10 in GF medium to give a stock for each experiment
and then added to the medium in the wells at no more than 1:4
dilution. The use of methanol was controlled for by using methanol
alone at the relevant dilutions in the medium and after the cultures
were exposed to it for 24 h. Quercetin (Sigma, UK) was dissolved in
1 Ò NaOH to give a 100 mÒ stock and then further diluted in GF
medium to give a 1 mÒ stock and a 10 mÒ stock. Quercetin was
then added to the culture medium at no more than a 1:10 dilution.
The pH of all solutions following changes in composition remained
in the range pH 7·2 to 7·4.
To study the effects of lactate and metabolic inhibitors on synaptic
function in organotypic hippocampal slice cultures, we recorded
field potentials from the CA1 region in response to afferent
stimulation of the Schaffer collateral commissuralÏassociational
pathway. The membrane of the Millicell culture insert on which the
cultures were grown was carefully cut away from its support ring
and placed in a Peltier device-controlled microscope stage incubator
(Medical Systems Corp., USA) and cultures were perfused
continuously with artificial cerebro-spinal fluid (ACSF; mÒ): NaCl
117·8, glucose 10, MgSOÚ 1, CaClµ 2·5, KCl 3·3, KHµPOÚ 1·26,
NaHµPOÚ 26 , pH 7·4, 306 mosmol l¢ maintained at 34 ± 0·5°C
and oxygenated by bubbling through with 95% Oµ—5% COµ. A
stimulating electrode consisting of a pair of 0·28 mm twisted
polyamide-insulated steel wire (Plastics One, USA) was placed into
stratum lucidum at the transition between CA3 and CA1 to
stimulate the afferent fibres into the CA1 region. Glass micro-
recording electrodes were pulled on a standard electrode puller to a
tip resistance of 5 MÙ when filled with 2·5 Ò NaCl. Recording
electrodes were placed under visual guidance into the stratum
pyramidale of the CA1 region. Single or paired 0·1 ms monopolar
stimuli 0—20 V were delivered to the slice cultures at an interval of
no less than 10 s. Field potential population responses were
digitised (Axon Instruments, USA), recorded, stored and analysed
using software developed in-house (A2D, E. Stockley, Southampton
University). Population spike amplitudes and field EPSP rise times
were measured in response to increasing afferent stimulus intensity
(stimulus—response relationship) and a measure of recurrent
inhibition was also determined by delivering paired stimuli (15 ms
apart). Cultures that did not display paired-pulse inhibition or
which had population spikes of less than 2 mV at a stimulus of 20 V
were discarded from the study.
To study the effects of substrate modulation or metabolic inhibition
on synaptic function, paired stimuli of equal intensity were
delivered to the slice cultures at an intensity which was set at just
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below the intensity required to produce a maximal response as
determined from the stimulus—response curve (typically 10 V).
Experiments were started at t = −15 min to determine and record
a stable baseline to be established before starting the experimental
procedure at t = 0. At this point, the perfusion was switched from
the control glucose-containing ACSF to the appropriate experimental
condition. Responses at the appropriate stimulus intensity were
obtained every 5 min throughout the course of the experiment. At
the end of the insult period, the perfusion was switched back to
glucose-containing ACSF and the recovery of field potentials was
monitored for a further 30 min.
RESULTS
Our initial experiments focused on determining the
sensitivity of the slice cultures to interruption of supply of
energy generating substrate. Glucose deprivation for 24 h
was not toxic (Fig. 1). This observation suggests that there
are significant energy stores in these cultures that are
utilised in the absence of exogenous substrates. As neurons
do not store significant energy substrates this implies that
energy must be supplied by astrocytes and other satellite
cells present in the culture. We investigated the role of
monocarboxylate (principally lactate and pyruvate)
transport by blocking MCTs with the selective inhibitor
4_CIN. 4-CIN treatment (0·5 mÒ) for 24 h resulted in a
significant level of damage in CA1, CA3 and DG regions of
the cultures. 4-CIN treatment in the presence of exogenous
glucose had no effect indicating that this concentration of
4_CIN was not acting as a non-specific cytotoxin, nor was it
primarily acting as a mitochondrial pyruvate transport
blocker (Halestrap & Denton, 1974; Halestrap, 1975) (Fig. 1).
As 4-CIN is a reversible, competitive, substrate site directed
inhibitor of MCT we next checked that exogenous lactate
could compete with the inhibitor. Co-application of 5 mÒ
lactate with 0·5 mÒ 4-CIN resulted in less damage than
4-CIN alone, as expected if 4-CIN can be competitively
displaced. Damage in CA3 was reduced almost to the
unmeasurable level seen in the absence of 4-CIN (Fig. 1).
Lactate replacement alone did not cause any damage (data
not shown), and thus increasing exogenous lactate is not
toxic per se.
We next looked at the effects of varying concentrations of
4-CIN on the amount of damage at 24 h in the absence of
glucose (Fig. 2). The data show a concentration-dependent
increase in damage at 24 h, with the CA1 and dentate
granule cell layers showing greater sensitivity to 4-CIN than
the CA3 region. Damage became maximal at 2·5—5 mÒ.
This shows that 0·5 mÒ 4-CIN has a submaximal effect
which supports the explanation that partial reversal of the
4-CIN effect by lactate was due to substrate competition.
Attempts to produce similar damage with quercetin, 5-fold
more potent than 4-CIN on MCT2 (Broer et al. 1999) were
confounded by quercetin auto-fluorescence and anti-oxidant
effects in the same concentration range (Gao et al. 2000) that
might be protective. Quercetin (70 ìÒ) induced modest
damage in CA1 (11·7 ± 4·8% ; n = 24, P > 0·05, relative to
control).
The resistance of these cultures to glucose deprivation
suggests they have significant metabolisable energy stores.
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Figure 1. 4-CIN is toxic in the absence of substrate
Neuronal viability is maintained for 24 h in the absence of exogenous energy substrate but addition of the
monocarboxylate transport inhibitor 4-CIN is toxic in the absence of substrate. 4-CIN shows no non-
specific toxicity in the presence of glucose. All treatments were for 24 h. 4, CA1; 5, CA3; and fl, dentate
granule cell regions of the cultures. Data bars are means ± s.e.m.: no exogenous substrate, n = 24; 0·5 mÒ
4-CIN in the absence of substrate, n = 24; 0·5 mÒ 4-CIN + 5 mÒ lactate, n = 23; 0·5 mÒ
4-CIN + 30 mÒ glucose, n = 22. Significance was tested against damage induced by 0·5 mÒ 4-CIN.
**P < 0·05.
 at Univ Hertfordshire on December 21, 2007 jp.physoc.orgDownloaded from 
We tested the role of glycolysis in supplying this energy by
blocking glycolysis with 10 mÒ 2-deoxyglucose in the
absence of glucose. This treatment resulted in maximal
damage in all neuronal regions indicating an important role
for glycolysis in maintaining neuronal viability in the absence
of simple substrates. Addition of exogenous lactate should
circumvent the glycolytic blockade by 2_deoxyglucose by
supplying substrate downstream of the block. Addition of
5 mÒ lactate with 2-deoxyglucose did protect significantly
compared with 2-deoxyglucose alone and this protective
effect of 2-deoxyglucose was prevented by addition of
4-CIN (Fig. 3).
The ability to image the whole slice culture enabled us to
further examine the regional specificity of the various insults.
Control serum free cultures and cultures exposed to 0·5 mÒ
4-CIN in the presence of glucose showed no significant PI
signal in any region of the slice (Fig. 4A). Images taken from
slice cultures exposed to 10 mÒ 2_deoxyglucose in glucose-
free medium for 24 h show that a PI signal was evident in all
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Figure 3. The effect of blockade of glycolysis with 2-deoxyglucose (2-DG)
2-Deoxyglucose, 10 mÒ, added in the absence of energy substrate resulted in maximal damage in all
neuronal regions. Toxicity was reduced with the addition of lactate and the protective effect of lactate was
reversed with 4-CIN. Data bars are means ± s.e.m.: 10 mÒ 2-DG, n = 24; 10 mÒ 2-DG + 5 mÒ lactate,
n = 22; 10 mÒ 2-DG + 5 mÒ lactate + 0·5 mÒ 4-CIN, n = 24. Significance was tested vs. 10 mÒ 2-DG
alone in glucose-free medium; **P < 0·05.
Figure 2. Concentration—response curve for damage induced by 4-CIN treatment
Cultures were exposed to 4-CIN for 24 h in the absence of exogenous energy substrate. Data bars are
means ± s.e.m.: 0 mÒ 4-CIN, n = 16; 0·25 mÒ, n = 24; 0·5 mÒ, n = 14; 1 mÒ, n = 24; 2·5 mÒ, n = 22;
5 mÒ, n = 23.
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regions of the culture and not limited to the neuronal cell
layers (Fig. 4B). In contrast, the damage evoked by 0·5 mÒ
4-CIN incubation was confined to the CA1, CA3 and dentate
granule neuronal cell layers (Fig. 4C).
The substrate dependence of synaptic function has been
explored in acute slice preparations (Izumi et al. 1997) but
not in these organotypic cultures, so we were interested to
see the acute effects of substrate manipulation on synaptic
function. We recorded population spikes in the CA1 region
following Schaffer collateral pathway stimulation in slice
cultures exposed for 60 min to substrate changes andÏor
inhibitor (Fig. 5). As expected from the cell viability
measures, glucose removal for 1 h had little effect, and
replacement with 5 mÒ lactate completely prevented the
trend to run-down of population spike amplitude seen in
the absence of glucose. Both 2-deoxyglucose application in
the absence of glucose and 4-CIN application in the absence
of glucose caused a depression in population spike amplitude
that reached greater than 50% inhibition after 60 min. As
with the cell viability measures at 24 h, co-application of
lactate was able to partially reverse the effects of 4-CIN
(Fig. 5).
DISCUSSION
The results presented here can be accommodated by the
basic model of metabolic substrate supply interactions in
neuroglia proposed by Tsacopoulos & Magistretti (1996).
This is outlined in Fig. 6 and emphasises the major role of
lactate derived from glial glycogen and glucose as a neuronal
energy source. Although, the earliest experimental support
was obtained using the honey bee retina as a model where
lactate is not the exchange currency (Tsacopoulos et al.
1988), subsequently, supporting data have been generated in
mammalian CNS tissue (Schurr et al. 1988; Izumi et al.
1997). Our data clearly show that inhibition of the mono-
carboxylate transporter is toxic to neurons in the absence of
exogenous energy substrates when energy must be supplied
from stores. This toxicity can be prevented either by lactate
or glucose addition (Fig. 1). This is consistent with the
proposal that firstly, energy derived from energy stores is
supplied to neurons via monocarboxylate transport as
shown in pathway (3) in Fig. 6 and that this pathway may
be the most significant route of energy transfer from these
stores. Secondly, exogenous glucose is directly available as a
substrate to glia and possibly neurons. The fact that glucose
can rescue from MCT block might be explained two ways.
Glucose could be directly taken up by neurons. Alternatively,
it could be transported into glia and processed into lactate
in sufficient concentration to overcome MCT block. As Fig. 2
shows that 0·5 mÒ 4-CIN is submaximal, any lactate
production by glia in addition to glycogen store-derived
lactate should immediately start to reverse the block.
Finally, glucose transfer from glia to neurons (2) is not
significant as otherwise MCT block, in the absence of added
energy substrates, would not be toxic.
Exogenous lactate rescues neurons from 4-CIN toxicity
(Fig. 1). This could be due to straight competition on the
transporter or it could mean that 4-CIN is more potent on
the glial MCT exporting lactate and is less effective at
preventing exogenous uptake into neurons through the
neuronal MCT. If the latter were the case, then exogenous
lactate would effectively bypass the site of blockade (Fig. 6).
This would require expression of two different MCT
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Figure 4. Damage induced by glycolytic and mono-
carboxylate inhibition is differentially localised
Fluorescence images of organotypic hippocampal slice
cultures taken after 24 h exposed to control, serum free,
showing no PI damage (A); and 10 mÒ 2-DG in the absence
of exogenous energy substrate (B). PI signal was seen in all
regions of the culture indicating damage to both glial and
neuronal cell populations. C, 0·5 mÒ 4-CIN in the absence of
exogenous energy substrate. The damage evoked by 4-CIN
incubation was confined to the CA1, and dentate granule
neuronal cell layers. The remainder of the culture showed
little fluorescence, indicating minimal damage to glia.
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isoforms in the appropriate locations. Of the eight known
MCTs, protein distribution patterns are published for only
MCT1 and MCT2 both of which are expressed in the CNS
(reviewed by Halestrap & Price, 1999). In addition MCT7
and MCT8 mRNAs are relatively abundant in the human
brain (Price et al. 1998). Localisation data and the kinetic
properties of the transporters are consistent with MCT1
being the major glial MCT. MCT2 or another isoform may be
the predominant form on neurons (Halestrap & Price, 1999).
In situ hybridisation data show strong expression of MCT2
mRNA in CA1 and DG cell body layers in the hippocampus
(Pellerin et al. 1998). This would suit flux of lactate
predominantly from glia to neurons using the higher affinity
for lactate of MCT2 (Broer et al. 1998, 1999). 4-CIN blocked
MCT2 about 20-fold more potently than MCT1 when the rat
transporters were expressed in Xenopus oocytes. IC50 values
were 0·024 mÒ for MCT2 and 0·42 mÒ for MCT1 with
0·05 mÒ lactate (Broer et al. 1999). Thus, in our experiments,
relief of 4-CIN block of MCT1 by 5 mÒ lactate will be
greater, but taking into account the 100-fold lower substrate
concentrations used in the oocyte experiments, MCT2
block is also likely to be relieved. Thus, simple substrate
competition is the most parsimonious explanation of this
data rather than effects on the glial MCT. Further dissection
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Figure 5. Acute effects of block of energy substrate supply on synaptic transmission in CA1
region of slice cultures
Addition of either 10 mÒ 2-deoxyglucose or 0·5 mÒ 4-CIN in glucose-free ACSF led to >50% decrease in
the population spike height. The following substrates or blockers were added for t = 0—60 min; control
superfusion with ACSF containing glucose (A), no exogenous energy substrate (B), 5 mÒ lactate (C), 10 mÒ
2-DG in the absence of energy substrate (D), 0·5 mÒ 4-CIN in the absence of energy substrate (E), 0·5 mÒ
4-CIN in the presence of 5 mÒ lactate (F). Wash out, 30 min with glucose containing ACSF followed.
Means ± s.e.m. n = 4—5.
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of the roles of different MCT isoforms will depend on more
specific pharmacological blockade or gene knockout
experiments.
2-Deoxyglucose would be expected to be taken up both by
glia and neurons and thence to block glycolysis. This might
be expected to be equally damaging to both neurons and
glia (Fig. 6). Our observation of non-specific damage in the
presence of 2-deoxyglucose is thus consistent with this
model. This result also further emphasises the specific
nature of the damage induced by MCT inhibition. In the
presence of 4_CIN, lactate supply is cut off to neurons but
the glia are largely unaffected. This is consistent with the
energy supply in the absence of exogenous substrate
originating from glycogen stores in glia which would be
unaffected by this manoeuvre.
The reduced sensitivity of synaptic transmission to removal
of exogenous substrate in these slice cultures is in contrast to
the sensitivity of acute adult hippocampal slices (Schurr et
al. 1988). This might reflect larger energy stores in the slices
as a consequence of the time in tissue culture or the lack of
maturity of the tissue, or a more flexible use of other
metabolic substrates in these cultures. The dependence of
neuronal viability on MCT transport, suggests that a larger
glycogen store in glia or more generous glial:neuronal ratio
is the most parsimonious explanation. Glial fibrillary acidic
protein (GFAP) stained cultures show a high number of
astrocytic processes within the culture and astrocytes can
be seen to envelop the entire culture suggesting that they
are present in increased numbers compared with acute slices
(Pringle et al. 1997).
The intact brains of neonates, unlike adults, are able to
utilise the rich circulating supply of lactate, pyruvate and
other substrates at birth and whilst suckling (Cremer, 1982;
Vicario et al. 1991; Nehlig & de Vasconcelos, 1993). This
transient adaptation to monocarboxylate substrate supply
in blood is in part achieved by a transient increase in
expression of MCT1 in brain capillary endothelial cells
(Pellerin et al. 1998). Our data suggest that the subsequent
handling of substrates is very similar to that of adult brain
parenchyma, with the lactate shuttle between glia and
neurons playing a prominent role. The comparability of
metabolic state of these slice cultures to the in situ properties
of neonatal hippocampus has been poorly explored. Other
properties examined show morphological and functional
maturation at the same rate as in situ (reviewed by Gahwiler
et al. 1997). Thus these cultures probably best represent the
developmental status in situ at P15—25.
This new work highlights the role of the MCT family of
transporters as key proteins in the maintenance of energy
supply to neurons. Given the long term deleterious effects
of metabolic stress on neurons and the likely association
with neurodegenerative conditions (Mark et al. 1997),
examination of this family of proteins might be a
productive area to search for linkage with genetic diseases.
The genes for MCT1 and MCT2 are localised on chromosome
1p13.2 (Garcia et al. 1994) and 12q13 (Lin et al. 1998). No
specific disease linkages to these regions or to those of
other known MCTs have been reported to date in the
On-Line Mendelian Inheritance in Man (OMIM) database
(http:ÏÏwww.ncbi.nlm.nih.govÏomim). Disruption at some
point in this pathway may be an important source of
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Figure 6. Energy supply to neurons and glia
Diagram showing the main sources and routes of energy supply to neurons in the slice model based on the
lactate shuttle hypothesis (Tsacopoulos & Magistretti, 1996). The potential sources are (1) exogenous
glucose, (2) glucose supplied from glia, (3) monocarboxylates (principally lactate) supplied from glia derived
either from glycogen stores or from glucose uptake, andÏor (4) exogenous lactate. 4-CIN blocks mono-
carboxylate transporters (MCT) in glia and neurons. 2-DG blocks glucose metabolism. Our data are
consistent with pathway (3) being the major pathway.
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metabolic stress leading to neuronal loss in neuro-
degenerative diseases.
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